Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Obesity × Glucose Tolerance Test × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 2 Fatty Liver 2 Diabetes Mellitus 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Obesity 1 Neoplasms 1 Lymphoma 1 Iron Overload 1 Hemoglobinopathies 1 Glucose Metabolism Disorders 1 Glucose Intolerance 1 Fibrous Dysplasia, Polyostotic 1 Fibrous Dysplasia of Bone 1

Interventions

Blood Specimen Collection 5 Surveys and Questionnaires 3 semaglutide 2 exemestane 2 Tirzepatide 2 Tamoxifen 2 Observation 2 Esophagectomy 2 Biopsy 2 BaseLine dental cement 2 Bariatric Surgery 2 Anastrozole 2 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Utrogestan 1 Urine Specimen Collection 1 Topiramate 1 Testosterone 1 Stents 1 Resistance Training 1 Qsymia 1 Progestins 1 Phentermine 1 Nutrition Assessment 1 Naltrexone 1 Metabolic Networks and Pathways 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Medical History Taking 1 Mammography 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03041129 2024-04-17

PLUM

University of Colorado, Denver

19 enrolled 10 charts

Fatty Liver, Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡